Sage Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	3,063	2,626	-	-	-	-	Upgrade
Enterprise Value	6,800	5,778	-	-	-	-	Upgrade
Last Close Price	38.87	35.01	-	-	-	-	Upgrade
PE Ratio	22.02	22.82	-	-	-	-	Upgrade
PS Ratio	2.39	2.43	-	-	-	-	Upgrade
PB Ratio	2.17	2.10	-	-	-	-	Upgrade
P/TBV Ratio	2.26	2.19	-	-	-	-	Upgrade
EV/Sales Ratio	5.30	5.35	-	-	-	-	Upgrade
EV/EBITDA Ratio	25.06	25.06	-	-	-	-	Upgrade
EV/EBIT Ratio	26.29	26.35	-	-	-	-	Upgrade
Debt / Equity Ratio	2.71	2.48	3.49	3.88	4.54	1.97	Upgrade
Debt / EBITDA Ratio	14.75	13.49	11.16	9.19	18.17	20.40	Upgrade
Asset Turnover	0.25	0.23	0.20	0.30	0.22	-	Upgrade
Inventory Turnover	0.34	0.30	0.19	0.32	0.27	-	Upgrade
Quick Ratio	0.19	0.11	0.07	0.09	0.07	0.10	Upgrade
Current Ratio	1.18	1.04	1.05	1.09	0.99	1.12	Upgrade
Return on Equity (ROE)	12.64%	11.94%	22.50%	51.70%	39.08%	-	Upgrade
Return on Assets (ROA)	2.94%	2.92%	3.97%	5.42%	3.38%	-	Upgrade
Return on Capital (ROIC)	3.39%	3.38%	4.46%	6.26%	4.07%	-	Upgrade
Return on Capital Employed (ROCE)	8.10%	10.00%	18.50%	23.00%	14.90%	4.60%	Upgrade
Earnings Yield	4.26%	4.38%	-	-	-	-	Upgrade
FCF Yield	-29.29%	-10.19%	-	-	-	-	Upgrade
Payout Ratio	-	17.38%	-	8.70%	1.70%	4.67%	Upgrade
Buyback Yield / Dilution	-23.20%	-15.49%	-	-	-	-	Upgrade
Total Shareholder Return	-	-15.49%	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.